Seelos Therapeutics, Inc. Accounts Payable
Seelos Therapeutics, Inc. had Accounts Payable of $15.69 million as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2024-08-14
- 2024-06-30: Accounts Payable, Current $15.69M.
- 2024-03-31: Accounts Payable, Current $15.27M.
- 2023-12-31: Accounts Payable, Current $16.40M.
- 2023-09-30: Accounts Payable, Current $9.32M.
| Period end | Accounts Payable, Current |
|---|---|
| 2024-06-30 | $15.69M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $15.27M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $16.40M 10-Q · filed 2024-08-14 |
| 2023-09-30 | $9.32M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $6.44M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $5.96M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.63M 10-K · filed 2024-03-06 |
| 2022-09-30 | $5.95M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.31M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $2.13M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.69M 10-K · filed 2023-03-10 |
| 2021-09-30 | $3.40M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $1.04M 10-Q · filed 2021-08-06 |
| 2020-12-31 | $1.89M 10-K · filed 2022-03-04 |